DIALYSIS · CCN 452788

SHC KYLE

KYLE, TX 78640

DialysisProfitUS Renal Care, Inc.
$5.4M
TOTAL REVENUE
5.7%
OPERATING MARGIN
5 / 5
STAR RATING
15
QUALITY MEASURES
US Renal Care, Inc.
CHAIN
01 — FINANCIAL

Cost report financials (FY2025)

Net patient revenue
$5.4M
Total costs
$5.0M
Operating income (rev − costs)
$304K
Operating margin
5.7%
Total charges
$5.4M
Total treatments
14,120
Dialysis stations
25

Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.

02 — QUALITY MEASURES

15 quality measures

MeasureScoreDenominatorPeriod
Percent of Adult HD Patients with Kt/V >= 1.2
DFC_ADULT_HD_KTV
97100—
Standardized ED Visits Within 30 Days of Hospital Discharge
DFC_ED30
0.5642—
Fistula Rate
DFC_FISTULA_RATE
62.3112—
Five Star Rating
DFC_FIVE_STAR
5——
First Year Standardized Kidney Transplant Waitlist Ratio
DFC_FYSWR
1.1855—
Healthcare Worker COVID-19 Vaccination Adherence
DFC_HCP_VACC
0——
Patient Hospitalization Rate
DFC_HOSPITALIZATION_RATE
97.996—
Percentage of Adult Patients with Hypercalcemia
DFC_HYPERCALCEMIA
2103—
Standard Infection Ratio (SIR)
DFC_INFECTION_RATIO
0——
Percentage of Adult Patients with Long Term Catheter in Use
DFC_LONG_CATHETER
9112—
Patient Survival (Mortality Rate)
DFC_MORTALITY_RATE
26.4362—
Percentage of Prevalent Patients Waitlisted for Kidney Transplant
DFC_PPPW
20.888—
Patient Hospital Readmission Rate
DFC_READMISSION_RATE
17.153—
Standardized ED Visits Ratio
DFC_SEDR
0.7440—
Patient Transfusion Rate
DFC_TRANSFUSION_RATE
15.338—